We are live on ! Find out more
XTNT icon

Xtant Medical Holdings

30 hedge funds and large institutions have $59.1M invested in Xtant Medical Holdings in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

31% more capital invested

Capital invested by funds: $45.3M → $59.1M (+$13.8M)

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

7% more funds holding

Funds holding: 2830 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

11.87% less ownership

Funds ownership: 69.27%57.39% (-12%)

Holders
30
Holders Change
+2
Holders Change %
+7.14%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
6
Increased
7
Reduced
6
Closed
4
Calls
Puts
Net Calls
Net Calls Change

XTNT Hedge Fund Activity: Q2 2025 in Review

30 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q2 2025, worth a combined $59.1M — up 31% from $45.3M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new XTNT positions and 4 closed out — a net gain of 2 holders — while 7 added to existing stakes and 6 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $32.4M. The largest seller was OrbiMed, exiting entirely with an estimated $34.4M sold.

  • 30 institutional investors held Xtant Medical Holdings (XTNT) as of Q2 2025, up from 28 in Q1 2025.
  • Funds reported $59.1M of Xtant Medical Holdings stock for Q2 2025, up 31% quarter-over-quarter.
  • 6 funds opened new Xtant Medical Holdings positions in Q2 2025 and 4 closed out, a net change of +2 holders.
  • The largest Xtant Medical Holdings buyer in Q2 2025 was Nantahala Capital Management, an estimated $32.4M added.
  • The largest Xtant Medical Holdings seller in Q2 2025 was OrbiMed, an estimated $34.4M sold.

Based on aggregated 13F filings for Q2 2025.